Advanced Biomedical Research   Report issue

For profit Phase 1 Phase 2
Founded: Las Vegas NV United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2006
NCT00516659
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Advanced Biomedical Research, Hackensack, NJ | Advanced Biomedical Research, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

heat-labile enterotoxin of e. coli (1 trial)

Drugs in Phase 1 Trials (2)

srx-246 (1 trial)

srx-251 (2 trials)

Drugs in Other Trials (2)

famciclovir (famvir) (1 trial)

protriptyline (vivactil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 5